Delivery Order SPE2DB24D9803-SPE2DB25FJSFM
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,586.22 to DMS Pharmaceutical Group Inc. for 30 units of Triumeq 600-50-300 mg tablets. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with a completion date of September 12, 2025. This delivery order was issued without a set-aside designation, allowing the company to compete on a full and open basis despite its small business...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,690.47 firm fixed-price delivery order is for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a specialized pharmaceutical product. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This IDC...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,052.71 for Emtricitabine and related pharmaceutical products by the Defense Logistics Agency (DLA) Medical Supply Chain. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 25, 2025, represents a single transaction under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,017.57 by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, with completion expected by August 25, 2025. The delivery order, issued without a set-aside designation, covers the supply of Emtricitabine and related pharmaceutical products to support federal healthcare requirements. This award is issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,017.57 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The delivery order, which covers Emtricitabine and related pharmaceutical products, is set to be completed by August 11, 2025, with performance taking place at the contractor's Park Ridge facility. This award was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,017.57 for emtricitabine and related pharmaceutical products by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a task order under DMS Pharmaceutical Group's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,017.57 by the Defense Logistics Agency's Medical Supply Chain division on August 13, 2025. The award covers the supply of Emtricitabine and related pharmaceutical products, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was issued without a set-aside designation, allowing the contractor to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $1,017.57 by the Defense Logistics Agency's Medical Supply Chain division. This delivery order, issued on August 4, 2025, with an ultimate completion date of August 14, 2025, is for the supply of Emtricitabine and related pharmaceutical products. The award carries no set-aside designation, allowing DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $1,017.57 for Emtricitabine and related pharmaceutical products. The contract, awarded on September 12, 2025, with an ultimate completion date of September 22, 2025, is issued under the Defense Logistics Agency's SPE2DB Indefinite Delivery Contract program—a $500 million vehicle that enables the issuance of delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,017.57 by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with completion scheduled for September 8, 2025. The contract is for Emtricitabine and related pharmaceutical products under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- SPE2DB24D9803Indefinite Delivery Contract
- SPE2DB24D9803-SPE2DB25FJSFMDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 18, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $10,656.59 with an ultimate completion date of June 20, 2025, was issued without a set-aside designation. The award falls under the company's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which enables the agency to issue delivery orders for comprehensive pharmaceutical products supporting military healthcare facilities worldwide. DMS Pharmaceutical Group leverages its position as a crucial supplier in the federal pharmaceutical supply chain to provide direct distribution of prescription drugs and medical supplies to Department of Defense healthcare sites. The company's extensive contract portfolio with DLA encompasses branded and generic prescription medications, biologics, and medical consumables across multiple product categories. This particular delivery order for TRIUMEQ—an antiretroviral medication used in HIV treatment—represents continued execution of the company's core business of supplying essential pharmaceutical products to federal healthcare systems across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 6/18/25 |